期刊
CURRENT DIABETES REPORTS
卷 17, 期 5, 页码 -出版社
CURRENT MEDICINE GROUP
DOI: 10.1007/s11892-017-0857-4
关键词
Diabetic ketoacidosis; Management; Survey; Hyperglycemic hyperosmolar state
资金
- Merck Co.
Purpose of Review Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS) are diabetic emergencies that cause high morbidity and mortality. Their treatment differs in the UK and USA. This review delineates the differences in diagnosis and treatment between the two countries. Recent Findings Large-scale studies to determine optimal management of DKA and HHS arc lacking. The diagnosis of DKA is based on disease severity in the USA, which differs from the UK. The diagnosis of HHS in the USA is based on total rather than effective osmolality. Unlike the USA, the UK has separate guidelines for DKA and HHS. Treatment of DKA and HHS also differs with respect to timing of fluid and insulin initiation. Summary There is considerable overlap but important differences between the UK and USA guidelines for the management of DKA and HHS. Further research needs to be done to delineate a unifying diagnostic and treatment protocol.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据